These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 24327329)

  • 1. Targeting inflammation: impact on atherothrombosis.
    Marini MG; Sonnino C; Previtero M; Biasucci LM
    J Cardiovasc Transl Res; 2014 Feb; 7(1):9-18. PubMed ID: 24327329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-based immunotherapy targeting cytokines and atherothrombotic cardiovascular diseases.
    Ait-Oufella H; Libby P; Tedgui A
    Arch Cardiovasc Dis; 2020 Jan; 113(1):5-8. PubMed ID: 31917124
    [No Abstract]   [Full Text] [Related]  

  • 3. Inflammation and cardiovascular diseases: lessons from seminal clinical trials.
    Liberale L; Montecucco F; Schwarz L; Lüscher TF; Camici GG
    Cardiovasc Res; 2021 Jan; 117(2):411-422. PubMed ID: 32666079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial: update on inflammatory targets modulating atherogenesis.
    Carbone F; Mach F; Montecucco F
    Curr Drug Targets; 2015; 16(4):282-3. PubMed ID: 25859799
    [No Abstract]   [Full Text] [Related]  

  • 5. Interplay between inflammation and thrombosis in cardiovascular pathology.
    Stark K; Massberg S
    Nat Rev Cardiol; 2021 Sep; 18(9):666-682. PubMed ID: 33958774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of CLEC-2 and Its Ligands in Thromboinflammation.
    Meng D; Luo M; Liu B
    Front Immunol; 2021; 12():688643. PubMed ID: 34177942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherosclerosis revisited from a clinical perspective: still an inflammatory disease?
    Santovito D; Weber C
    Thromb Haemost; 2017 Jan; 117(2):231-237. PubMed ID: 27975102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation in atherosclerosis: transition from theory to practice.
    Libby P; Okamoto Y; Rocha VZ; Folco E
    Circ J; 2010 Feb; 74(2):213-20. PubMed ID: 20065609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and atherosclerosis: what is on the horizon?
    Ruparelia N; Choudhury R
    Heart; 2020 Jan; 106(1):80-85. PubMed ID: 31843811
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel anti-inflammatory therapies for the treatment of atherosclerosis.
    Khan R; Spagnoli V; Tardif JC; L'Allier PL
    Atherosclerosis; 2015 Jun; 240(2):497-509. PubMed ID: 25917947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antiplatelet therapy on inflammatory markers in atherothrombotic patients.
    Muhlestein JB
    Thromb Haemost; 2010 Jan; 103(1):71-82. PubMed ID: 20062914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential role of antiplatelet agents in modulating inflammatory markers in atherothrombosis.
    Yeh ET; Khan BV
    J Thromb Haemost; 2006 Nov; 4(11):2308-16. PubMed ID: 16961584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic strategies for atherosclerosis and atherothrombosis: Past, present and future.
    Weber C; Badimon L; Mach F; van der Vorst EPC
    Thromb Haemost; 2017 Jun; 117(7):1258-1264. PubMed ID: 28594053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyphosphate as modulator of hemostasis, thrombosis, and inflammation.
    Morrissey JH; Smith SA
    J Thromb Haemost; 2015 Jun; 13 Suppl 1(0 1):S92-7. PubMed ID: 26149055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atherothrombosis Prevention and Treatment with Anti-interleukin-1 Agents.
    Biondi-Zoccai G; Garmendia CM; Abbate A; Giordano A; Frati G; Sciarretta S; Antonazzo B; Versaci F
    Curr Atheroscler Rep; 2020 Jan; 22(1):4. PubMed ID: 31932973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting inflammation in cardiovascular diseases. still a neglected field?
    Gómez-Guerrero C; Mallavia B; Egido J
    Cardiovasc Ther; 2012 Aug; 30(4):e189-97. PubMed ID: 21884009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of anti-inflammatory agents for treatment of atherosclerosis.
    Chistiakov DA; Melnichenko AA; Grechko AV; Myasoedova VA; Orekhov AN
    Exp Mol Pathol; 2018 Apr; 104(2):114-124. PubMed ID: 29378168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the immune response in atherosclerosis: It's time for clinical trials!
    Joffre J; Ait-Oufella H
    Arch Cardiovasc Dis; 2017 Dec; 110(12):643-645. PubMed ID: 29051009
    [No Abstract]   [Full Text] [Related]  

  • 19. The Utility of Anti-Inflammatory Agents in Cardiovascular Disease: A Novel Perspective on the Treatment of Atherosclerosis.
    Kottoor SJ; Arora RR
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):483-493. PubMed ID: 29783850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting factor Xa and thrombin: impact on coagulation and beyond.
    Esmon CT
    Thromb Haemost; 2014 Apr; 111(4):625-33. PubMed ID: 24336942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.